178 related articles for article (PubMed ID: 16709446)
1. General aspects of immunotoxicology including validation issues.
Frieke Kuper C
Exp Toxicol Pathol; 2006 Jul; 57(5-6):363-6. PubMed ID: 16709446
[TBL] [Abstract][Full Text] [Related]
2. The immune system--multiple sites but one system.
Harleman JH
Exp Toxicol Pathol; 2006 Jul; 57(5-6):359-61. PubMed ID: 16730433
[TBL] [Abstract][Full Text] [Related]
3. Regulatory aspects of immunotoxicology.
Schulte A; Ruehl-Fehlert C
Exp Toxicol Pathol; 2006 Jul; 57(5-6):385-9. PubMed ID: 16713214
[TBL] [Abstract][Full Text] [Related]
4. The ICH S8 immunotoxicity guidance. Immune function assessment and toxicological pathology: autonomous or synergistic methods to predict immunotoxicity?
Spanhaak S
Exp Toxicol Pathol; 2006 Jul; 57(5-6):373-6. PubMed ID: 16723215
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic approaches to detect changes indicative of immunotoxicity.
Kuper CF; Harleman JH; Richter-Reichelm HB; Vos JG
Toxicol Pathol; 2000; 28(3):454-66. PubMed ID: 10862566
[TBL] [Abstract][Full Text] [Related]
6. Histopathology of the immune system as a tool to assess immunotoxicity.
Schuurman HJ; Kuper CF; Vos JG
Toxicology; 1994 Feb; 86(3):187-212. PubMed ID: 8128503
[TBL] [Abstract][Full Text] [Related]
7. The immune system as a target for chemical toxicity.
Revillard JP
Eur Cytokine Netw; 1991; 2(2):81-7. PubMed ID: 1813018
[No Abstract] [Full Text] [Related]
8. Harmonization of immunotoxicity guidelines in the ICH process--pathology considerations from the guideline Committee of the European Society of Toxicological Pathology (ESTP) .
Ruehl-Fehlert C; Bradley A; George C; Germann PG; Bolliger AP; Schultee A;
Exp Toxicol Pathol; 2005 Aug; 57(1):1-5. PubMed ID: 16089314
[TBL] [Abstract][Full Text] [Related]
9. STP position paper: best practice guideline for the routine pathology evaluation of the immune system.
Haley P; Perry R; Ennulat D; Frame S; Johnson C; Lapointe JM; Nyska A; Snyder P; Walker D; Walter G;
Toxicol Pathol; 2005; 33(3):404-7; discussion 408. PubMed ID: 15805080
[No Abstract] [Full Text] [Related]
10. Pathology of toxic effects on the immune system.
Gopinath C
Inflamm Res; 1996 Dec; 45 Suppl 2():S74-8. PubMed ID: 8988406
[TBL] [Abstract][Full Text] [Related]
11. Enhanced histopathology evaluation of lymphoid organs.
Elmore SA
Methods Mol Biol; 2010; 598():323-39. PubMed ID: 19967523
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric immunotoxicity screening in mice during early drug development.
Aulí M; Domènech A; Andrés A; Orta M; Salvà M; Descotes J; Prats N
Toxicol Lett; 2012 Oct; 214(2):200-8. PubMed ID: 22944472
[TBL] [Abstract][Full Text] [Related]
13. Immune function tests for hazard identification: a paradigm shift in drug development.
Gore ER
Basic Clin Pharmacol Toxicol; 2006 Apr; 98(4):331-5. PubMed ID: 16623854
[TBL] [Abstract][Full Text] [Related]
14. Responses of the immune system to injury.
Descotes J; Choquet-Kastylevsky G; Van Ganse E; Vial T
Toxicol Pathol; 2000; 28(3):479-81. PubMed ID: 10862568
[TBL] [Abstract][Full Text] [Related]
15. Juvenile toxicity testing protocols for chemicals.
Piersma AH; Tonk EC; Makris SL; Crofton KM; Dietert RR; van Loveren H
Reprod Toxicol; 2012 Nov; 34(3):482-6. PubMed ID: 22564981
[TBL] [Abstract][Full Text] [Related]
16. Report of validation study of assessment of direct immunotoxicity in the rat. The ICICIS Group Investigators. International Collaborative Immunotoxicity Study.
Toxicology; 1998 Feb; 125(2-3):183-201. PubMed ID: 9570332
[TBL] [Abstract][Full Text] [Related]
17. Extended histopathology in immunotoxicity testing: interlaboratory validation studies.
Germolec DR; Nyska A; Kashon M; Kuper CF; Portier C; Kommineni C; Johnson KA; Luster MI
Toxicol Sci; 2004 Mar; 78(1):107-15. PubMed ID: 14691208
[TBL] [Abstract][Full Text] [Related]
18. Methodologies for developmental immunotoxicity (DIT) testing.
Dietert RR; Holsapple MP
Methods; 2007 Jan; 41(1):123-31. PubMed ID: 17161309
[TBL] [Abstract][Full Text] [Related]
19. The transferability from rat subacute 4-week oral toxicity study to translational research exemplified by two pharmaceutical immunosuppressants and two environmental pollutants with immunomodulating properties.
Kemmerling J; Fehlert E; Kuper CF; Rühl-Fehlert C; Stropp G; Vogels J; Krul C; Vohr HW
Eur J Pharmacol; 2015 Jul; 759():326-42. PubMed ID: 25823813
[TBL] [Abstract][Full Text] [Related]
20. Approaches to the identification and recording of findings in the lymphoreticular organs indicative for immunotoxicity in regulatory type toxicity studies.
Harleman JH
Toxicology; 2000 Jan; 142(3):213-9. PubMed ID: 10667892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
